MBRX icon

Moleculin Biotech
MBRX

Overview Fund Activity

24 hedge funds and large institutions have $5.31M invested in Moleculin Biotech in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.35M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.04M
3
BlackRock
3
BlackRock
New York
$141K
4
Morgan Stanley
4
Morgan Stanley
New York
$39K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$20K

Top Sellers

1
CH
1
CVI Holdings
Delaware
$0
2
AC
2
Armistice Capital
New York
$0
3
Bank of America
3
Bank of America
North Carolina
$0
4
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$12K
5
IWP
5
Icon Wealth Partners
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
– -$20K -278 Closed
IWP
27
Icon Wealth Partners
Texas
– -$1K -16 Closed
1
2